Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVT201 for insomnia disorder (phase 3, China)
CTR20201068Phase 3Completed
- Sponsor
- Jingxin Pharmaceutical
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dimdazenil in Insomnia, sponsored by Jingxin Pharmaceutical. Started Jun 2020; status: completed.
02
Drugs
dimdazenil
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20201068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201068.